NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 55 filers reported holding NUVALENT INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,917,551 | +144.9% | 172,233 | +124.6% | 0.00% | – |
| Q2 2023 | $3,233,131 | +71.0% | 76,669 | +5.8% | 0.00% | – |
| Q1 2023 | $1,890,769 | -17.8% | 72,471 | -6.2% | 0.00% | – |
| Q4 2022 | $2,300,000 | +104.8% | 77,233 | +33.7% | 0.00% | – |
| Q3 2022 | $1,123,000 | +27.2% | 57,752 | -11.2% | 0.00% | – |
| Q2 2022 | $883,000 | +158.2% | 65,049 | +163.8% | 0.00% | – |
| Q1 2022 | $342,000 | +102.4% | 24,655 | +178.3% | 0.00% | – |
| Q4 2021 | $169,000 | +704.8% | 8,858 | +864.9% | 0.00% | – |
| Q3 2021 | $21,000 | – | 918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $368,253,000 | 7.72% |
| Fairmount Funds Management LLC | 914,614 | $17,414,000 | 5.74% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $65,269,000 | 5.18% |
| VR Adviser, LLC | 803,951 | $15,307,000 | 2.09% |
| Boxer Capital, LLC | 1,210,192 | $23,042,000 | 0.90% |
| Avoro Capital Advisors LLC | 1,102,671 | $18,431,000 | 0.31% |
| BVF INC/IL | 448,512 | $8,540,000 | 0.31% |
| Logos Global Management LP | 134,650 | $2,563,000 | 0.26% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,180,696 | $22,480,000 | 0.23% |
| Perceptive Advisors | 1,500,000 | $28,560,000 | 0.22% |